|
2024-12-04 |
2024-12-02 |
S
Sale
|
Simonian Nancy A
Non-Executive Director
|
37,070
-90.3%
0.27
USD 10,016
|
37,070
-90.3%
|
0.27
|
USD 10,016
|
|
|
2024-11-27 |
2024-11-25 |
S
Sale
|
Simonian Nancy A
Non-Executive Director
|
134,713
-76.6%
0.27
USD 35,739
|
134,713
-76.6%
|
0.27
|
USD 35,739
|
|
|
2024-11-20 |
2024-11-19 |
S
Sale
|
Quirk Gerald E
Chief Legal & Compliance Offic
Officer
|
46,657
-100.0%
0.22
USD 10,321
|
46,657
-100.0%
|
0.22
|
USD 10,321
|
|
|
2024-11-20 |
2024-11-18 |
S
Sale
|
Chee Conley
President & CEO
Executive Director
|
134,797
-100.0%
0.20
USD 26,932
|
134,797
-100.0%
|
0.20
|
USD 26,932
|
|
|
2024-11-20 |
2024-11-18 |
S
Sale
|
Roth David
Chief Medical Officer
Officer
|
12,099
-100.0%
0.20
USD 2,382
|
12,099
-100.0%
|
0.20
|
USD 2,382
|
|
|
2024-11-20 |
2024-11-18 |
S
Sale
|
Stephens Kristin
Chief Development Officer
Officer
|
36,133
-100.0%
0.22
USD 7,949
|
36,133
-100.0%
|
0.22
|
USD 7,949
|
|
|
2024-11-20 |
2024-11-18 |
S
Sale
|
Haas Jason
Chief Financial Officer
Officer
|
137,803
-100.0%
0.21
USD 28,980
|
137,803
-100.0%
|
0.21
|
USD 28,980
|
|
|
2024-09-12 |
2024-09-12 |
B
Purchase
|
Haas Jason
Chief Financial Officer
Officer
|
45,344
+57.2%
1.68
USD 76,006
|
45,344
+57.2%
|
1.68
|
USD 76,006
|
|
|
2024-09-12 |
2024-09-11 |
B
Purchase
|
Haas Jason
Chief Financial Officer
Officer
|
19,293
+32.2%
1.58
USD 30,446
|
19,293
+32.2%
|
1.58
|
USD 30,446
|
|
|
2024-09-12 |
2024-09-11 |
B
Purchase
|
Chee Conley
President & CEO
Executive Director
|
50,000
+69.0%
1.71
USD 85,420
|
50,000
+69.0%
|
1.71
|
USD 85,420
|
|
|
2024-09-12 |
2024-09-10 |
B
Purchase
|
Haas Jason
Chief Financial Officer
Officer
|
35,363
+144.0%
1.55
USD 54,788
|
35,363
+144.0%
|
1.55
|
USD 54,788
|
|
|
2024-09-12 |
2024-09-10 |
B
Purchase
|
Chee Conley
President & CEO
Executive Director
|
50,000
+222.2%
1.51
USD 75,260
|
50,000
+222.2%
|
1.51
|
USD 75,260
|
|
|
2024-07-02 |
2024-06-28 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
34,837
-81.3%
5.12
USD 178,365
|
34,837
-81.3%
|
5.12
|
USD 178,365
|
|
|
2024-04-05 |
2024-04-03 |
PS
Planned sale
|
Roth David
Chief Medical Officer
Officer
|
10,451
-100.0%
4.95
USD 51,732
|
10,451
-100.0%
|
4.95
|
USD 51,732
|
|
|
2024-04-02 |
2024-04-02 |
PS
Planned sale
|
Roth David
Chief Medical Officer
Officer
|
150
-1.4%
4.98
USD 747
|
150
-1.4%
|
4.98
|
USD 747
|
|
|
2023-12-26 |
2023-12-21 |
B
Purchase
|
AKKARAJU SRINIVAS
Non-Executive Director
|
904,977
+102.7%
4.42
USD 3,999,998
|
904,977
+102.7%
|
4.42
|
USD 3,999,998
|
|
|
2023-12-14 |
2023-12-12 |
PS
Planned sale
|
Roth David
Chief Medical Officer
Officer
|
6,287
-100.0%
4.95
USD 31,121
|
6,287
-100.0%
|
4.95
|
USD 31,121
|
|
|
2023-12-08 |
2023-12-06 |
PS
Planned sale
|
Roth David
Chief Medical Officer
Officer
|
6,287
-50.0%
3.95
USD 24,834
|
6,287
-50.0%
|
3.95
|
USD 24,834
|
|
|
2023-08-02 |
2023-07-31 |
PS
Planned sale
|
Roth David
Chief Medical Officer
Officer
|
7,348
-100.0%
3.95
USD 29,025
|
7,348
-100.0%
|
3.95
|
USD 29,025
|
|
|
2023-07-18 |
2023-07-17 |
PS
Planned sale
|
Olson Eric R
Chief Scientific Officer
Officer
|
689
-9.4%
3.50
USD 2,412
|
689
-9.4%
|
3.50
|
USD 2,412
|
|
|
2022-10-03 |
2022-09-30 |
B
Purchase
|
TYSON TIMOTHY
Non-Executive Director
|
14,000
+128.1%
6.37
USD 89,186
|
14,000
+128.1%
|
6.37
|
USD 89,186
|
|
|
2022-10-03 |
2022-09-29 |
B
Purchase
|
TYSON TIMOTHY
Non-Executive Director
|
2,932
+36.6%
5.72
USD 16,770
|
2,932
+36.6%
|
5.72
|
USD 16,770
|
|
|
2022-01-06 |
2022-01-05 |
PS
Planned sale
|
Olson Eric R
Chief Scientific Officer
Officer
|
2,208
-100.0%
3.47
USD 7,655
|
2,208
-100.0%
|
3.47
|
USD 7,655
|
|
|
2021-03-17 |
2021-03-15 |
PS
Planned sale
|
Olson Eric R
Chief Scientific Officer
Officer
|
3,628
-100.0%
9.47
USD 34,372
|
3,628
-100.0%
|
9.47
|
USD 34,372
|
|
|
2021-02-18 |
2021-02-16 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
3,750
-1.2%
12.05
USD 45,188
|
3,750
-1.2%
|
12.05
|
USD 45,188
|
|
|
2021-02-10 |
2021-02-08 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
3,750
-1.1%
13.04
USD 48,900
|
3,750
-1.1%
|
13.04
|
USD 48,900
|
|
|
2020-11-18 |
2020-11-17 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
5,357
-1.6%
8.75
USD 46,874
|
5,357
-1.6%
|
8.75
|
USD 46,874
|
|
|
2020-11-18 |
2020-11-16 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
633
-0.2%
8.98
USD 5,684
|
633
-0.2%
|
8.98
|
USD 5,684
|
|
|
2020-10-19 |
2020-10-19 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
5,673
-1.7%
8.75
USD 49,639
|
5,673
-1.7%
|
8.75
|
USD 49,639
|
|
|
2020-10-16 |
2020-10-15 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
317
-0.1%
8.75
USD 2,774
|
317
-0.1%
|
8.75
|
USD 2,774
|
|
|
2020-09-16 |
2020-09-15 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
5,990
-1.7%
10.39
USD 62,236
|
5,990
-1.7%
|
10.39
|
USD 62,236
|
|
|
2020-08-19 |
2020-08-18 |
PS
Planned sale
|
Olson Eric R
Chief Scientific Officer
Officer
|
10,787
-100.0%
13.00
USD 140,231
|
10,787
-100.0%
|
13.00
|
USD 140,231
|
|
|
2020-08-19 |
2020-08-18 |
PS
Planned sale
|
AKKARAJU SRINIVAS
Non-Executive Director
|
158,583
-11.1%
13.10
USD 2,076,724
|
158,583
-11.1%
|
13.10
|
USD 2,076,724
|
|
|
2020-08-19 |
2020-08-17 |
PS
Planned sale
|
Olson Eric R
Chief Scientific Officer
Officer
|
4,963
-100.0%
13.00
USD 64,519
|
4,963
-100.0%
|
13.00
|
USD 64,519
|
|
|
2020-08-19 |
2020-08-17 |
PS
Planned sale
|
AKKARAJU SRINIVAS
Non-Executive Director
|
744
-0.1%
13.00
USD 9,672
|
744
-0.1%
|
13.00
|
USD 9,672
|
|
|
2020-08-19 |
2020-08-17 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
5,990
-1.7%
12.59
USD 75,414
|
5,990
-1.7%
|
12.59
|
USD 75,414
|
|
|
2020-07-17 |
2020-07-15 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
5,990
-1.7%
11.85
USD 70,982
|
5,990
-1.7%
|
11.85
|
USD 70,982
|
|
|
2020-07-07 |
2020-07-07 |
PS
Planned sale
|
Olson Eric R
Chief Scientific Officer
Officer
|
1,753
-100.0%
11.72
USD 20,538
|
1,753
-100.0%
|
11.72
|
USD 20,538
|
|
|
2020-07-06 |
2020-07-01 |
PS
Planned sale
|
AKKARAJU SRINIVAS
Non-Executive Director
|
4,627
-0.3%
11.01
USD 50,966
|
4,627
-0.3%
|
11.01
|
USD 50,966
|
|
|
2020-06-25 |
2020-06-25 |
PS
Planned sale
|
AKKARAJU SRINIVAS
Non-Executive Director
|
54,972
-3.7%
11.15
USD 612,850
|
54,972
-3.7%
|
11.15
|
USD 612,850
|
|
|
2020-06-25 |
2020-06-24 |
PS
Planned sale
|
AKKARAJU SRINIVAS
Non-Executive Director
|
48,775
-3.2%
11.07
USD 539,788
|
48,775
-3.2%
|
11.07
|
USD 539,788
|
|
|
2020-06-25 |
2020-06-23 |
PS
Planned sale
|
AKKARAJU SRINIVAS
Non-Executive Director
|
50,953
-3.2%
11.11
USD 565,930
|
50,953
-3.2%
|
11.11
|
USD 565,930
|
|
|
2020-06-16 |
2020-06-15 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
5,990
-1.6%
8.75
USD 52,413
|
5,990
-1.6%
|
8.75
|
USD 52,413
|
|
|
2020-05-15 |
2020-05-15 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
5,990
-1.6%
9.22
USD 55,242
|
5,990
-1.6%
|
9.22
|
USD 55,242
|
|
|
2020-05-13 |
2020-05-13 |
B
Purchase
|
Alles Mark J
Non-Executive Director
|
10,000
+inf%
8.86
USD 88,590
|
10,000
+inf%
|
8.86
|
USD 88,590
|
|
|
2020-04-17 |
2020-04-15 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
23,960
-6.1%
8.75
USD 209,650
|
23,960
-6.1%
|
8.75
|
USD 209,650
|
|
|
2020-02-20 |
2020-02-18 |
PS
Planned sale
|
Olson Eric R
Chief Scientific Officer
Officer
|
1,446
-100.0%
7.38
USD 10,674
|
1,446
-100.0%
|
7.38
|
USD 10,674
|
|
|
2019-11-12 |
2019-11-12 |
PP
Planned purchase
|
Springhorn Jeremy P.
Chief Business Officer
Officer
|
10,121
+40.7%
4.97
USD 50,268
|
10,121
+40.7%
|
4.97
|
USD 50,268
|
|
|
2019-11-12 |
2019-11-11 |
PP
Planned purchase
|
Springhorn Jeremy P.
Chief Business Officer
Officer
|
9,879
+65.9%
4.99
USD 49,328
|
9,879
+65.9%
|
4.99
|
USD 49,328
|
|
|
2019-08-19 |
2019-08-16 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
22,700
-5.4%
10.00
USD 227,000
|
22,700
-5.4%
|
10.00
|
USD 227,000
|
|
|
2019-08-19 |
2019-08-15 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
2,300
-0.5%
10.00
USD 23,000
|
2,300
-0.5%
|
10.00
|
USD 23,000
|
|
|
2019-07-17 |
2019-07-17 |
S
Sale
|
ARCH Venture Fund VII, L.P.
Large shareholder
|
34,521
-0.8%
7.70
USD 265,687
|
34,521
-0.8%
|
7.70
|
USD 265,687
|
|
|
2019-07-17 |
2019-07-16 |
S
Sale
|
ARCH Venture Fund VII, L.P.
Large shareholder
|
25,779
-0.6%
7.81
USD 201,277
|
25,779
-0.6%
|
7.81
|
USD 201,277
|
|
|
2019-07-17 |
2019-07-15 |
S
Sale
|
ARCH Venture Fund VII, L.P.
Large shareholder
|
2,700
-0.1%
8.27
USD 22,316
|
2,700
-0.1%
|
8.27
|
USD 22,316
|
|
|
2019-04-11 |
2019-04-09 |
B
Purchase
|
AKKARAJU SRINIVAS
|
533,332
+50.3%
7.50
USD 3,999,990
|
533,332
+50.3%
|
7.50
|
USD 3,999,990
|
|
|
2019-03-14 |
2019-03-14 |
S
Sale
|
ARCH Venture Fund VII, L.P.
Large shareholder
|
43,000
-1.0%
8.15
USD 350,441
|
43,000
-1.0%
|
8.15
|
USD 350,441
|
|
|
2019-03-14 |
2019-03-13 |
S
Sale
|
ARCH Venture Fund VII, L.P.
Large shareholder
|
2,820
-0.1%
8.20
USD 23,122
|
2,820
-0.1%
|
8.20
|
USD 23,122
|
|
|
2019-03-14 |
2019-03-13 |
S
Sale
|
ARCH Venture Fund VII, L.P.
Large shareholder
|
81,591
-1.8%
7.89
USD 643,443
|
81,591
-1.8%
|
7.89
|
USD 643,443
|
|
|
2019-03-14 |
2019-03-12 |
S
Sale
|
ARCH Venture Fund VII, L.P.
Large shareholder
|
40,092
-0.9%
7.37
USD 295,374
|
40,092
-0.9%
|
7.37
|
USD 295,374
|
|
|
2019-03-11 |
2019-03-11 |
S
Sale
|
ARCH Venture Fund VII, L.P.
Large shareholder
|
44,878
-1.0%
6.49
USD 291,366
|
44,878
-1.0%
|
6.49
|
USD 291,366
|
|
|
2019-03-11 |
2019-03-08 |
S
Sale
|
ARCH Venture Fund VII, L.P.
Large shareholder
|
84,496
-1.8%
6.93
USD 585,270
|
84,496
-1.8%
|
6.93
|
USD 585,270
|
|
|
2019-03-11 |
2019-03-07 |
S
Sale
|
ARCH Venture Fund VII, L.P.
Large shareholder
|
35,209
-0.8%
6.87
USD 242,013
|
35,209
-0.8%
|
6.87
|
USD 242,013
|
|
|
2018-02-02 |
2018-01-31 |
B
Purchase
|
AKKARAJU SRINIVAS
Non-Executive Director
|
209,424
+24.6%
9.55
USD 1,999,999
|
209,424
+24.6%
|
9.55
|
USD 1,999,999
|
|
|
2017-12-15 |
2017-12-15 |
B
Purchase
|
Springhorn Jeremy P.
Chief Business Officer
|
15,000
+inf%
9.08
USD 136,260
|
15,000
+inf%
|
9.08
|
USD 136,260
|
|
|
2017-12-14 |
2017-12-14 |
B
Purchase
|
AKKARAJU SRINIVAS
|
26,600
+3.3%
8.99
USD 239,134
|
26,600
+3.3%
|
8.99
|
USD 239,134
|
|
|
2017-12-14 |
2017-12-13 |
B
Purchase
|
AKKARAJU SRINIVAS
|
68,400
+9.3%
8.97
USD 613,548
|
68,400
+9.3%
|
8.97
|
USD 613,548
|
|
|
2017-12-14 |
2017-12-12 |
B
Purchase
|
AKKARAJU SRINIVAS
|
14,774
+2.0%
9.40
USD 138,876
|
14,774
+2.0%
|
9.40
|
USD 138,876
|
|
|
2017-10-23 |
2017-10-23 |
PS
Planned sale
|
DeSimone Colleen Elizabeth
Principal Accounting Officer
Officer
|
550
-100.0%
16.06
USD 8,833
|
550
-100.0%
|
16.06
|
USD 8,833
|
|
|
2017-08-16 |
2017-08-14 |
PS
Planned sale
|
Young Richard A
|
3,282
-0.8%
22.00
USD 72,204
|
3,282
-0.8%
|
22.00
|
USD 72,204
|
|
|
2017-08-08 |
2017-08-07 |
PS
Planned sale
|
Olson Eric R
Chief Scientific Officer
|
2,500
-100.0%
23.59
USD 58,969
|
2,500
-100.0%
|
23.59
|
USD 58,969
|
|
|
2017-07-27 |
2017-07-25 |
PS
Planned sale
|
Olson Eric R
Chief Scientific Officer
Officer
|
12,500
-100.0%
21.85
USD 273,125
|
12,500
-100.0%
|
21.85
|
USD 273,125
|
|
|
2017-07-27 |
2017-07-25 |
PS
Planned sale
|
Young Richard A
Non-Executive Director
|
3,282
-0.8%
22.09
USD 72,496
|
3,282
-0.8%
|
22.09
|
USD 72,496
|
|
|
2016-07-07 |
2016-07-06 |
B
Purchase
|
Arch Venture Fund VII LP
Large shareholder
|
400,000
+9.4%
12.50
USD 5,000,000
|
400,000
+9.4%
|
12.50
|
USD 5,000,000
|
|
|
2016-07-07 |
2016-07-06 |
B
Purchase
|
Flagship Ventures Fund IV, L.P.
Large shareholder
|
80,000
+9.5%
12.50
USD 1,000,000
|
80,000
+9.5%
|
12.50
|
USD 1,000,000
|
|
|
2016-07-07 |
2016-07-06 |
B
Purchase
|
Flagship Ventures Fund IV, L.P.
Large shareholder
|
320,000
+9.5%
12.50
USD 4,000,000
|
320,000
+9.5%
|
12.50
|
USD 4,000,000
|
|
